Johnson Investment Counsel’s Collegium Pharmaceutical COLL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,157	Closed	-$239K	–	827
2025 Q4	$239K	Buy	+5,157	New	+$216K	﹤0.01%	734
2024 Q4	–	Sell	-6,436	Closed	-$249K	–	799
2024 Q3	$249K	Hold	6,436	–	–	﹤0.01%	699
2024 Q2	$207K	Sell	6,436 -886	-12%	-$30.7K	﹤0.01%	711
2024 Q1	$284K	Sell	7,322 -1,015	-12%	-$35.5K	﹤0.01%	622
2023 Q4	$257K	Buy	+8,337	New	+$209K	﹤0.01%	620
2023 Q3	–	Sell	-9,512	Closed	-$204K	–	689
2023 Q2	$204K	Sell	9,512 -686	-7%	-$15.6K	﹤0.01%	637
2023 Q1	$245K	Sell	10,198 -96,988	-90%	-$2.57M	﹤0.01%	590
2022 Q4	$2.49M	Sell	107,186 -19,954	-16%	-$402K	0.03%	206
2022 Q3	$2.04M	Buy	127,140 +1,507	+1%	+$26.6K	0.03%	214
2022 Q2	$2.23M	Sell	125,633 -1,712	-1%	-$28.8K	0.03%	205
2022 Q1	$2.59M	Buy	127,345 +1,520	+1%	+$28.7K	0.03%	202
2021 Q4	$2.35M	Buy	125,825 +1,243	+1%	+$24.2K	0.03%	217
2021 Q3	$2.46M	Buy	124,582 +33,813	+37%	+$731K	0.03%	197
2021 Q2	$2.15M	Sell	90,769 -172	-0.2%	-$3.97K	0.03%	207
2021 Q1	$2.15M	Buy	90,941 +5,581	+7%	+$133K	0.03%	202
2020 Q4	$1.71M	Buy	85,360 +1,350	+2%	+$26.4K	0.03%	216
2020 Q3	$1.75M	Buy	84,010 +26,808	+47%	+$484K	0.03%	198
2020 Q2	$1M	Buy	+57,202	New	+$1.12M	0.02%	282